Unlocking New Hope: Advances in the Application of Mesenchymal Stromal Cells in Female Infertility.

Several human studies show positive signals, while research methods and sample sizes continue to develop.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Mesenchymal stromal cell (MSC) therapy represents a rapidly evolving domain within regenerative medicine research and its clinical applications. As a therapeutic approach in regenerative medicine, MSCs therapy holds a distinct position in addressing female infertility, attributed to its low immunogenicity and robust capacities for self-renewal and differentiation. Empirical studies have demonstrated that the transplantation of MSCs derived from various sources, such as menstrual fluid, endometrium, bone marrow, adipose tissue, and umbilical cord, can effectively facilitate the restoration of ovarian and endometrial morphology and function. This offers promising prospects for the treatment of a range of female infertility-related conditions, including ovarian insufficiency, intrauterine adhesion, and polycystic ovary syndrome. This review article examines the underlying mechanisms and recent advancements in research on MSCs from diverse sources within the female reproductive system. Furthermore, it elucidates the application of MSCs in clinical trials targeting ovarian and endometrial pathologies.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.